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SummAry – The aim of this prospective study was to evaluate whether cytokine levels in nasal 
secretions may be clinical parameters of severity of nasal polyposis. forty nasal polyp patients (20 
asthmatic and 20 nonasthmatic) requiring surgical treatment were included. nasal secretion samples 
were collected from nasal cavities of all 40 subjects. The levels of t-helper type 1 (Th1) proinflam-
matory cytokines il-2, il-12, ifn-g, il-1β, tnf-α and tnf-β, Th2 cytokines il-4, il-5 and 
il-6, antiinflammatory cytokine il-10 and chemokine il-8 were measured using flow cytometric 
method. each of the 40 patients was staged clinically according to global nasal symptom score, 
endoscopic score, and lund-mackay computed tomography (Ct) score. eosinophils were counted 
in hematoxylin-eosin stained sections of all nasal polyp samples. The concentrations of Th2 proin-
flammatory cytokines il-5 and il-6 were significantly higher (p<0.05 and p<0.01, respectively) in 
patients with nasal polyposis and asthma compared with nasal polyp patients without asthma. Po-
sitive correlations were observed between il-2 concentration in nasal secretions and nasal symptom 
score, endoscopic score, and lund-mackay score only in nasal polyp patients without asthma. We 
also found positive correlation between lund-mackay score and the levels of il-8, il-4, and il-1β 
in nonasthmatic patients. A positive correlation between il-5 levels in nasal fluid and endoscopic 
score was found only in asthmatic patients. eosinophil counts were higher in asthmatic patients’ 
polyps compared with nonasthmatic ones, but without statistical significance. nasal polyposis in 
asthmatic patients has different immunological patterns compared to those without asthma. The 
concentrations of cytokines measured in nasal fluid were not sensitive enough to be universal criteria 
to determine the severity of all forms of nasal polyposis. 
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Introduction
nasal polyposis is a chronic inflammatory disease 
of the nasal and paranasal sinus mucosa, which is 
characterized by the formation of benign edematous 
polyps. most often, polyps originate from the anterior 
ethmoid complex and from there they can descend be-
tween the middle turbinate and the lateral nasal wall 
into the nasal cavity causing symptoms such as nasal 
obstruction, anosmia, sneezing, rhinorrhea, and itch-
ing1. Chronic persistent inflammation is a major fac-
tor in the development of nasal polyposis2. Polyp tis-
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sue includes mixed inflammatory cells, predominantly 
eosinophils and neutrophils. They have the primary 
role in perpetuation of chronic inflammation2,3. it 
has been suggested that an ineffective local t-helper 
1 (Th1)-based immune response in these patients is 
associated with increased t-helper 2 (Th2)-cytokine-
based activity, which contributes to chronic infection 
as well as to an increased presence of eosinophils, 
which then lead to further polyp formation4. it has 
been proposed that the weakened Th1 response in 
these patients may be secondary to the down-regula-
tion of some specific toll-like receptors involved in the 
innate immune response4. 
it was found that asthma was present in 29.9% of 
patients with nasal polyps referred to ent depart-
ments5. On the other hand, 7% of asthma patients had 
nasal polyps2,5. Asthma is the most common chronic 
disease among children and adolescents. it is charac-
terized by intermittent obstruction and inflammatory 
changes of airways and bronchial hyperresponsive-
ness6. The pathogenesis and pathophysiology of this 
disease are known to be associated with alterations of 
glucocorticoid receptor function and also with persis-
tent pulmonary inflammation, the important media-
tors of which are reactive oxygen and nitrogen spe-
cies7. 
nasal secretions represent a first line defense me-
dium, in which leukocytes probably act as an efficient 
part of the defense mechanism along with the mu-
cociliary transport system and mucus biochemical 
properties8. Cellular secretory products in nasal secre-
tions may be determined to characterize inflamma-
tory changes of the upper respiratory mucosa9. nasal 
secretions contain small amounts of cytokines, potent 
biologic factors involved in the regulation of inflam-
mation and immune defense, and other inflammatory 
mediators expressed by various epithelial and nonepi-
thelial cells10. it has been shown that nasal secretions 
reflect the inflammatory status of the nasal mucosa 
and the evolution of mucosal disease. However, the 
mechanisms of cytokine release in nasal fluid are less 
well known. results published by Ohkubo et al.11 
show that il-6 and il-8 were released to the nasal 
fluid mainly from the migrating and epithelial cells as 
a result of antigen provocation, reflex action of meta-
choline and by direct action of histamine. As cytok-
ines play a dominant role in the pathophysiology of 
airway disease, the cytokine profile in nasal secretions 
may help recognize the mechanisms underlying nasal 
polyposis. The key question in this study was: may cy-
tokine levels in nasal fluid be indicators of the nasal 
polyposis severity?
The aim of this study was to compare the levels of 
these cellular secretory products in nasal secretions of 
asthmatic and nonasthmatic patients with nasal pol-
yps and to correlate cytokine levels with clinical pa-




forty patients requiring surgical treatment (20 
subjects with nasal polyposis and 20 subjects with na-
sal polyposis and concomitant asthma) were included 
in this prospective study, which was performed ac-
cording to the declaration of Helsinki. A written in-
formed consent was obtained from all subjects. The 
study was approved by the ethics Committee of the 
military medical Academy, Belgrade, Serbia. There 
were 15 male and 5 female patients in the nasal polyp 
group (mean age 43.27±14.72 years) and 16 male and 4 
female patients in the nasal polyp with asthma group 
(mean age 46.52±15.31 years). The diagnosis of nasal 
polyposis was based on each patient’s medical history 
and on the results of anterior rhinoscopy, nasal endos-
copy and computed tomography according to the cur-
rent european Guidelines2. nasal polyposis, which is 
considered to be a subgroup of chronic rhinosinusitis, 
is defined as inflammation of the nose and parana-
sal sinuses, characterized by two or more symptoms, 
one of which should be either nasal blockage/obstruc-
tion/congestion or nasal discharge (anterior, posterior 
nasal drip) ± facial pain/pressure ± reduction or loss 
of sensation of smell and either endoscopic signs of 
polyps and/or mucopurulent discharge primarily from 
middle meatus and/or edema/mucosal obstruction 
primarily in middle meatus, and/or computed tomog-
raphy (Ct) changes showing mucosal changes within 
the ostiomeatal complex and/or sinuses for more than 
12 weeks2.
The diagnosis of nasal polyposis was confirmed by 
histopathologic analysis of nasal polyp specimens af-
ter endoscopic sinus surgery. twenty patients had the 
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diagnosis of mild persistent bronchial asthma. The di-
agnosis of asthma was made at the time of inclusion in 
the study according to the Global initiative on Asth-
ma (GinA)12. Assessment of the severity of asthma 
was done by a pulmonologist based on the patient’s 
medical history, clinical data and pulmonary func-
tion testing, including forced expiratory volume in 
1 second (fev1) and methacholine provocation test 
(mch Pd20). Only patients with polyps associated 
with mild bronchial asthma, without aspirin sensitiv-
ity were included in the study. The diagnosis of aspi-
rin-induced asthma was done by a positive bronchial 
aspirin-provocation test. The other exclusion criteria 
were the presence of antrochoanal and sphenochoanal 
polyps, aspirin sensitivity, cystic fibrosis, and prima-
ry ciliary dyskinesia. none of the study subjects had 
bronchial or respiratory tract infection and none of 
them was treated with oral and topical corticosteroids, 
antibiotics and antihistamines for at least three weeks 
before enrolment. All patients underwent skin prick 
test for sensitivity to eighteen common allergens. test 
result was considered positive when at least one of the 
induration diameters was by 3 mm higher than that in 
negative control. Subjects were considered allergic if 
they had a serum ige level >200 iu/ml. 
Clinical score
All patients were examined by the same otorhino-
laryngologist. The patients were asked to assess their 
symptoms associated with nasal polyposis. Only sub-
jects with nasal symptoms persisting for at least 12 
weeks were included in the study. The presence of 
nasal symptoms associated with nasal polyposis (ob-
struction, anosmia, sneezing, rhinorrhea, and itching) 
on the day of enrolment was scored according to tsi-
copoulos et al.13 from 0 to 3, as follows: 0 for no symp-
toms, 1 for mild symptoms, 2 for moderate symptoms, 
and 3 for severe symptoms, so that the maximal global 
nasal symptom score was 15.
nasal endoscopy was performed in sitting position 
with a rigid endoscope 0˚ and 30˚ (Storz, tuttlingen, 
Germany). topical anesthesia or decongestion were 
not used. endoscopic physical findings were scored 
according to lildholdt et al.14. The degree of nasal pol-
yps is classified in relation to fixed anatomical land-
marks in four steps: 0 = no polyposis; 1 = mild poly-
posis (small polyps not reaching the upper edge of the 
inferior turbinate); 2 = moderate polyposis (medium 
sized polyps reaching between the upper and lower 
edges of the inferior turbinate); and 3 = severe poly-
posis (large polyps reaching below the lower edge of 
the inferior turbinate). The maximal endoscopic score 
is 6, bilaterally.
findings on Ct scans were graded according to 
lund-mackay score15. mucosal abnormalities were 
graded as 0 (no abnormality), 1 (partial opacification), 
or 2 (total opacification) of the frontal, maxillary, an-
terior ethmoid, posterior ethmoid and sphenoid sinus, 
bilaterally. The ostiomeatal complexes were scored bi-
laterally as 0 (not occluded) or 2 (occluded). The maxi-
mal Ct grading score is 24.
Sampling of nasal secretions and cytokine determination
nasal secretion samples were collected from na-
sal cavities of all 40 subjects (20 patients with nasal 
polyposis and 20 patients with nasal polyposis and 
asthma) several days before endoscopic sinus surgery, 
using absorption technique with cotton-wool sticks 
(length 10 millimeters, diameter 4 millimeters; insti-
tute of virology, vaccine and Sera, torlak, Belgrade, 
Serbia), which were inserted into the nasal cavity for 
60 seconds, as previously described16,17. The samples 
were placed in a 2-ml eppendorf tube containing 1 
ml of transfer media (phosphate-buffered saline with 
gentamicin 50 μg/ml, penicillin G 340 u/ml, fun-
gizone 500 μg/ml) for 30 min to allow for diffusion 
of cytokines into the medium. nasal fluids were cen-
trifuged at 1000 g for 10 minutes to separate cellular 
components. After centrifugation, the supernatants 
were portioned and stored at -70 °C until cytokine de-
termination. The levels of eleven cytokines (tnf-α, 
tnf-β, il-1β, il-2, il-4, il-5, il-6, il-8, il-10, 
il-12, and ifn-g) were measured in all 40 samples 
using a commercial flow cytometric kit (flow Cyto-
mix, Bender medSystems GmbH, vienna, Austria) 
on a flow cytofluorimeter (Beckman Coulter Xl-
mCl, uSA), which was connected with BmS flow 
Cytomix Pro 2.2 Software, according to the manufac-
turer’s instructions. The sensitivity of detection was as 
follows: 22 pg/ml for tnf-α; 32 pg/ml for tnf-β; 
17 pg/ml for il-1β; 28 pg/ml for il-2; 20 pg/ml 
for il-4; 30 pg/ml for il-5; 21 pg/ml for il-6; 13 
pg/ml for il-8; 20 pg/ml for il-10; 5.1 pg/ml for 
il-12; and 8 pg/ml for ifn-g. 
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Tissue preparation and quantification of eosinophils 
All patients were operated endoscopically (feSS) 
under general anesthesia by the same surgeon. nasal 
polyps located in the middle meatus were surgically 
removed. for histologic examination, polyp speci-
mens were fixed in 10% formaldehyde, embedded in 
paraffin, cut with a microtome into 5-μm sections and 
stained with hematoxylin and eosin. Histologic exam-
ination was performed using a digital optical micro-
scope (nikon Coolscope), assisted with computerized 
image analysis system. This system was programmed 
by imageJ (Java-based image processing program)18. 
Once the glass slide was set, brightfield images could 
be viewed on the monitor. eosinophils were counted 
at X400 magnification. The visual field was oriented 
along the whole length of the epithelium basement 
membrane. to yield the mean number of eosinophils 
per high power field (HPf), 10 randomly chosen HPfs 
of a single section were examined. The eosinophils in 
each section were counted, and the mean number of 
eosinophils per HPf was calculated.
Statistical analysis
data were expressed as mean ± standard deviation 
(± Sd). Statistical comparisons of the results were 
performed by using the nonparametric mann-Whit-
ney u test and χ2-test. Correlations between different 
parameters were made by Pearson’s correlation test. A 
p value of less than 0.05 was considered statistically 
significant. On statistical analysis, we used Stat Plus 
2007 program as a computerized analysis system.
Results
Comparing two groups (nasal polyposis with asth-
ma and nasal polyposis without asthma), we found no 
significant difference according to the global nasal 
symptom score, endoscopic score and lund-mackay 
score. eight patients in the nasal polyp group and 
twelve patients in the nasal polyp with asthma group 
were atopic. This finding showed a higher percentage 
of subjects with allergy in the nasal polyp with asthma 
group than in the nasal polyp group (p<0.05; χ2-test).
We found no significant differences in the levels 
of tnf-α, tnf-β, il-1β, il-2, il-4, il-8, il-
12, and ifn-g in the nasal secretions either. The 
concentrations of il-5, il-6 and il-10 in nasal 
fluid were significantly higher in patients with na-
sal polyposis and asthma compared to patients with 
nasal polyposis without asthma (635.37±585.08 pg/
ml vs. 273.48±218.12 pg/ml, p<0.05 for il-5; 
284.66±235.64 pg/ml vs. 56.63±77.16 pg/ml, p<0.01 
for il-6; and 82.12±61.25 pg/ml vs. 35.69±47.22 pg/
ml, p<0.05 for il-10). numerical cytokine levels are 
presented in table 2. 
Positive correlations were observed between the 
concentration of Th1 proinflammatory cytokine il-2 
and global nasal symptom score (r=0.600; p=0.018), 
endoscopic score (r=0.544; p=0.036), and lund-
Table 1. Characteristics of study population
 nasal polyposis nasal polyposis + asthma
Patients (n) 20 20
Age (yrs) 43.27±14.72 46.52±15.31
male/female ratio 15/5 16/4
fev1 100.54±4.81 95.22±5.35
mchPd20 (μg) 1589.38±57.73 548.83±101.78
Allergic 8 12
nonallergic 12 8
nasal symptom score 10.4±2.05 11.74±2.78
nasal endoscopic score 5.1±1.23 6.24±1.84
lund-mackay score 17.44±3.16 18.8±3.21
All results are expressed as mean ± Sd fev1 = forced expiratory volume in 1 second; mch Pd20 (μg) = 
amount of methacholine in micrograms
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mackay score (r=0.522; p=0.046) only in patients 
with nasal polyposis without asthma. We also found 
positive correlation between lund-mackay score and 
the levels of il-8 (r=0.522; p=0.046), il-4 (r=0.518; 
p=0.048) and il-1β (r=0.548; p=0.034) in nonasth-
matic patients. finally, our results showed positive 
correlation between il-5 levels in nasal fluid and en-
doscopic score (r=0.578; p=0.029) only in asthmatic 
patients.
On histopathologic examination, in asthmatic 
patients’ polyps, the subepithelial loose connective 
tissue and epithelial layer were infiltrated by numer-
ous eosinophils. in nonasthmatic patients’ polyps, the 
eosinophil infiltration of the epithelium and lamina 
propria was scarce (fig. 1 a, b). However, there was no 
statistically significant difference in the number of eo-
sinophils (asthmatics 37±8 and nonasthmatics 24±6) 
(fig. 2).
Table 2. Cytokine levels in nasal secretions
Cytokine nasal polyposis nasal polyposis with asthma p value
mean ± Sd mean ± Sd
il-12 8.38±14.31 29.78±47.82 >0.05
ifn-g 31.27±28.08 45.57±39.28 >0.05
il-2 248.85±186.67 174.72±123.62 >0.05
il-10 35.69±47.22 82.12±61.25 <0.05
il-8 172.34±223.19 137.88±103.22 >0.05
il-6 56.63±77.16 284.66±235.64 <0.01
il-4 523.68±735.42 968.87±1328.83 >0.05
il-5 273.48±218.12 635.37±585.08 <0.01
il-1β 29.27±48.46 48.85±43.93 >0.05
tnf-α 26.47±24.63 36.45±41.82 >0.05
tnf-β 171.38±227.37 202.88±323.53 >0.05
All results of cytokine levels are expressed in pg/ml.
Sd = standard deviation; il = interleukin; ifn = interferon; tnf = tumor necrosis factor
Fig. 1. In the polyps of asthmatic patients (a) the lamina propria and epithelium were infiltrated by numerous eosinophils, 
whereas in nonasthmatic patients’ polyps (b) this  eosinophil infiltration was scarce (H & E staining, X00). 
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Discussion
According to our results, the presence of asthma 
does not modify the symptoms, endoscopic and ra-
diographic characteristics of nasal polyposis. How-
ever, we found significant influence of asthma on the 
cytokine profiles in nasal fluid.  Hamilos et al.19 found 
significantly higher levels of il-5 in nasal polyp tis-
sue from asthmatic than those from nonasthmatic 
subjects. The results of our research also showed a 
significantly higher concentration of Th2 cytokines 
(il-5 and il-6) in nasal secretions from patients 
with nasal polyposis and asthma than in those with-
out asthma. These findings underline local Th1/Th2 
balance as a key factor that governs local inflamma-
tion, implying that there is a different mechanism in 
nasal polyp evolution in asthmatic and nonasthmatic 
patients.  
Previous data point to il-5 as one of the key pro-
teins in the pathomechanism of tissue eosinophilia, 
enhancing the differentiation, activation, expansion, 
mobilization, and in situ survival of eosinophils20. it is 
widely accepted that il-5 plays an important role in 
the pathogenesis of bronchial asthma, where il-5 in-
duces eosinophil mobilization, B-cell growth and dif-
ferentiation20. eosinophils and mast cells have been 
reported as the main sources of il-520,21. Preliminary 
findings reported by fan et al.21 suggest that t-cell-
derived il-5 and autosecretion of il-5 from activated 
eosinophils could be the reasons for the extension and 
persistence of eosinophil inflammation in nasal pol-
yps. Although we did not find statistically significant 
difference, the number of eosinophils was evidently 
higher in lamina propria of asthmatic patients’ polyps 
than in nonasthmatic ones. Therefore, the presence 
of fields of epithelial eosinophil infiltration is a clear 
confirmation of higher aggressiveness of eosinophilic 
inflammatory process in asthmatic patients. As il-5 
is a key inflammatory mediator in the development of 
nasal polyps associated with asthma and allergy, these 
findings could be an explanation of the positive cor-
relation between il-5 levels in nasal fluid and endo-
scopic score as an indicator of the spread of nasal pol-
yps. Although an increased number of il-5 mrnA 
was found in the ethmoid sinus mucosa at the time 
of surgery in patients that did not respond to surgi-
cal intervention22, drviš et al.23 found a positive cor-
relation between baseline il-5 level in sinus lavage 
and improvement rate of the sinusitis symptom score. 
Their results showed the increased il-5 levels in sinus 
fluid to predict good response to endosinusal steroid/
antibiotic treatment.
il-6 is an important proinflammatory Th2 type 
cytokine involved in the induction of ige synthesis as 
well as in mast cell proliferation and maturation20,24. 
il-6 also stimulates fibroblast proliferation and colla-
gen synthesis20,24. immunohistochemical staining and 
in situ hybridization also indicated that macrophages, 
eosinophils, fibroblasts, and lining epithelium were 
the main sources of il-620,24. The pathogenesis of na-
sal polyposis involves nasal polyp fibroblasts through 
synthesizing il-6 to modulate the activation of im-
mune responses (plasma cell formation) and synthesis 
of stroma20,24. van Zele et al.25 demonstrated an in-
creased colonization of nasal polyps by Staphylococcus 
aureus and presence of specific ige directed against 
Staphylococcus aureus exotoxins in nasal polyp tissue. 
The rate of colonization and ige presence in nasal 
polyp tissue were increased in subjects with nasal 
polyposis and asthma comorbidity23. Hellings et al.26 
demonstrated the nasal application of Staphylococcus 
aureus exotoxin B in mice to be capable of aggravat-
ing experimental allergic rhinitis and asthma, paral-
leled with an increase in bronchial and systemic Th2 
cytokine levels. il-10 is an anti-inflammatory Th2 
cytokine produced by t-lymphocytes, monocytes and 
macrophages. it is considered to inhibit the release of 
ifn-g and cytokine synthesis of monocytes, and leads 
to marked immunosuppression27. 
Fig. 2. The eosinophil count was higher in the polyp tissue 
samples from asthmatic patients (1) than in samples from 
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Positive correlations between il-4, il-1β, and 
il-8 levels in nasal secretions and lund-mackay score 
can be explained by several recently published find-
ings. eosinophil infiltration is regulated by numerous 
chemokines and adhesion molecules such as eotaxin, 
regulated on activation normal t cell expressed and 
secreted (rAnteS), and vascular cell adhesion mol-
ecule (vCAm)-120,28. in order to infiltrate the sites of 
inflammation, eosinophils leave the bloodstream and 
pass through the endothelium in four steps, namely 
rolling, adhesion, transendothelial migration, and 
chemotaxis20. Adhesion molecules, such as vCAm-1, 
play an important role during adhesion to endothelial 
cells20.  
Among other Th2 cytokines, il-4 has been shown 
to deliver signals that support or cause selective influx 
of eosinophils20,28. it has been speculated that il-4 
may be involved in the induction of vCAm-1 expres-
sion on microvascular endothelium in nasal polyps20,28. 
A study performed by yoshifuku et al.28 showed that 
il-4 increased the secretion of eotaxin and vCAm-1 
from cultured nasal polyp fibroblasts. 
il-1β has a crucial role in the pathogenesis of 
chronic rhinosinusitis and nasal polyps. This strong 
Th1 proinflammatory cytokine secreted by epithelial 
cells, monocytes, macrophages and fibroblasts up-
regulates the expression of e-selectin and intercellular 
adhesion molecule-1 (iCAm-1) in vascular endotheli-
al cells, and thereby induces extravascular transmigra-
tion of neutrophils29. The emigrated neutrophils then 
secrete il-1β, which amplifies the expression of e-
selectin and iCAm-1, resulting in further neutrophil 
infiltration29. il-1β can lead to increased transend-
othelial migration of eosinophils30. results published 
by Saji et al.30 suggest that nasal polyp fibroblasts play 
an important role in inducing eosinophilic infiltra-
tion, through il-1β induced production of rAnteS 
in nasal polyp fibroblasts. In vitro effects of rAnt-
eS on eosinophils include chemotaxis, transendothe-
lial migration, induction and production of reactive 
oxygen, and the release of eosinophil cationic protein 
(eCP)30. il-8, a potent neutrophil and also eosino-
phil chemoattractant and activating factor, is known 
to be released by monocytes, macrophages and air-
way epithelial cells20,27. recent data have shown that 
airway fibroblasts are also important sources of this 
chemokine20,27. il-8 is a very important chemokine 
regarding its chemotactic activity for neutrophils (and 
also eosinophils) in all types of rhinosinusitis and 
nasal polyposis. This chemotactic factor, released in 
nasal discharge from nasal gland duct cells and epi-
thelial cells, attract neutrophils out of the mucosa27. 
The neutrophils that have migrated into the sinus ef-
fusion secrete il-8. This induces further neutrophil 
accumulation in the sinus effusion27.   
Positive correlations between the concentration of 
il-2 and nasal symptom score, endoscopic score and 
lund-mackay score in nonasthmatic nasal polyp pa-
tients is difficult to explain. il-2 is an essential growth 
factor for t-cells and it acts in an autocrine fashion to 
stimulate t-cell proliferation and also serves to regu-
late immunoglobulin production and the growth of 
cytotoxic t-lymphocytes and natural-killer cells6. it 
has been suggested that nasal polyps present a mixed 
Th1 type and Th2 type cytokine profile4. We specu-
late that il-2 as a strong Th1 cytokine maybe have 
predominant role in the pathogenesis of nonasthmatic 
patients’ polyps, where the presence of atopy is not 
dominant. However, its role in the development of 
nasal polyposis is unclear and presents a topic for fur-
ther investigation. 
Conclusion     
Our results demonstrated the presence of Th2 
cytokines, especially il-5 and il-6 in nasal fluid in 
nasal polyp patients to be a prominent feature related 
to the increased inflammatory process. Our findings 
also suggest that up-regulation of Th2 cytokines is a 
more significant characteristic of nasal polyposis in 
asthmatic than nonasthmatic patients. These results 
showed that these patients with similar clinical find-
ings had significantly different mediator profiles in 
their nasal secretions, implying clear differences in the 
pathogenesis of their nasal polyps. The concentrations 
of il-4, il-8 and il-1β correlated with lund-mack-
ay Ct score as an indicator of the disease severity only 
in nonasthmatic nasal polyp patients. in asthmatic na-
sal polyp patients, il-5 levels in nasal fluid correlated 
with endoscopic clinical findings. in different types 
of nasal polyposis (asthmatics and nonasthmatics), 
different cytokines correlated with different clinical 
parameters. Although the concentrations of cytokines 
measured in nasal fluid were not sensitive enough to 
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determine the severity of all types of nasal polypo-
sis, evaluation of local immune reaction mediators in 
nasal secretions could be an accessible and valuable 
path in monitoring these patients and evaluating the 
pathogenesis of this disease. 
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Sažetak
kOnCentrACiJe PrOuPAlniH CitOkinA u nOSnOm Sekretu kAO indikAtOri
teŽine nOSne POliPOZe
A. Perić, d. vojvodić, v. radulović, B. vukomanović-Đurđević, A.v. Perić i O. miljanović
Cilj ove prospektivne studije bio je ispitati mogu li koncentracije citokina u nosnom sekretu poslužiti kao klinički para-
metri za procjenu težine nosne polipoze. u studiju je bilo uključeno 40 bolesnika s nosnom polipozom (20 astmatičnih i 20 
neastmatičnih) u kojih je bilo potrebno kirurško liječenje. uzorci nosnoga sekreta bili su sakupljeni iz nosnih šupljina svih 
40 bolesnika. koncentracije t pomoćničkih-1 (Th1) proupalnih citokina il-2, il-12, ifn-g, il-1β, tnf-α i tnf-β, 
Th2 citokina il-4, il-5 i il-6, protuupalnog citokina il-10 i hemokina il-8 mjerene su primjenom metode protočne 
citometrije. Svaki od 40 bolesnika klinički je klasificiran prema zbiru nosnih simptoma, endoskopskom zbiru i lund-mac-
kayevu zbiru. eozinofili su se brojili u uzorcima nosnih polipa obojenim tehnikom hematoksilin-eozin. koncentracije Th2 
proupalnih citokina il-5 i il-6 bile su statistički značajno više u astmatičnih nego u neastmatičnih bolesnika s nosnom 
polipozom (P<0,05, P<0,01). nađena je pozitivna korelacija između koncentracije il-2 u nosnom sekretu i zbira nosnih 
simptoma, endoskopskog zbira i lund-mackayeva zbira samo u neastmatičnih bolesnika. također su utvrđene pozitivne 
korelacije između lund-mackayeva zbira i razina il-8, il-4 i il-1β u neastmatičnih bolesnika. Pozitivna koralacija 
između koncentracije il-5 u nosnom sekretu i endoskopskog zbira nađena je samo kod astmatičnih bolesnika. Broj eozi-
nofila bio je veći u tkivu nosnih polipa astmatičnih bolesnika nego u neastmatičnih, ali bez statističke značajnosti. nosna 
polipoza u astmatičnih bolesnika ima drugačiji imunološki tijek u usporedbi s neastmatičnim bolesnicima. koncentracije 
citokina mjerene u nosnom sekretu nisu dovoljno osjetljiv pokazatelj da bi bile univerzalni kriterij za procjenu težine svih 
oblika nosne polipoze.
ključne riječi: Nosni polipi – komplikacije; Nosni polipi – dijagnostika; Nosni polipi – etiologija; Astma – komplikacije; Cito-
kini – lučenje; Respiracijska preosjetljivost - imunologija

